Theme
Obesity
The anti-obesity drug market and its knock-on effects across health.
The anti-obesity drug market centers on incretin therapies that produce significant, sustained weight loss. Its growth carries knock-on effects across cardiovascular, metabolic, and other areas of health.
Companies · 8
Amgen Inc.AMGN
Market cap$236B
Conviction5 / 5
GLP-1Obesity
Read profileEli Lilly and CompanyLLY
Market cap$1.2T
Conviction5 / 5
GLP-1Obesity
Read profileMadrigal Pharmaceuticals, Inc.MDGL
Market cap$8.8B
Conviction4 / 5
Metabolic diseaseObesity
Read profileNovo Nordisk A/SNVO
Market cap$126B
Conviction4 / 5
GLP-1Obesity
Read profilePfizer Inc.PFE
Market cap$156B
Conviction3 / 5
Obesity
Read profileViking Therapeutics, Inc.VKTX
Market cap$3.2B
Conviction3 / 5
ObesityMetabolic disease
Read profileZealand Pharma A/SZEAL
Market cap$2.0B
Conviction3 / 5
ObesityGLP-1
Read profileStructure Therapeutics Inc.GPCR
Market cap$1.2B
Conviction2 / 5
ObesityGLP-1
Read profile